Before flibanserin, there were no FDA-approved treatments for hypoactive sexual desire disorder. The authors clarify the intricacies of an HSDD diagnosis and discuss implications for treatment.
Jacob McBride, DO
Advertisement
Articles by Jacob McBride, DO
Advertisement
Latest Updated Articles
Does Flibanserin Have a Future?Published: January 1st 2016 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Patent Issued for Rapid Blood Tests to Differentiate Schizophrenia and Bipolar Disorder
2
When Symptoms Are Not Necessarily Signs of Illness: Rethinking Synchronicity in Psychiatry
3
Study Finds Semaglutide Is Associated With Improved Cognitive Function in Individuals With Psychiatric Disorders
4
International Stuttering Awareness Day: Why Psychiatrists Should Pay Attention
5
